PMLiVE’s Top Pharma List is live!; Omnichannel – breaking down the barriers; Rare diseases – improving patient access ...

AstraZeneca (AZ) has announced that it will be expanding its cell therapy capabilities by acquiring EsoBiotec for up to $1bn. The deal will give AZ access to EsoBiotec’s Engineered NanoBody Lentiviral ...

The National Institute for Health and Care Excellence (NICE) has recommended Pharming’s Joenja (leniolisib) to treat patients with the ultra-rare immune disease, activated phosphoinositide 3-kinase ...

Boehringer Ingelheim (BI) and Salipro Biotech have entered into a partnership aimed at accelerating the development of ...

Prime Minister Sir Keir Starmer announced the abolition of NHS England to "cut bureaucracy" and bring management of the ...